Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
<i>Background and Objectives</i>: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances. Despite several therapeutic approaches being available, bot...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/9/525 |
id |
doaj-08c76ed9140343f8a465542101bd10ff |
---|---|
record_format |
Article |
spelling |
doaj-08c76ed9140343f8a465542101bd10ff2020-11-24T21:50:01ZengMDPI AGMedicina1010-660X2019-08-0155952510.3390/medicina55090525medicina55090525Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic ReviewLaura Orsolini0Stefania Chiappini1Umberto Volpe2Domenico De Berardis3Roberto Latini4Gabriele Duccio Papanti5John Martin Corkery6Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB Herts, UKPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB Herts, UKDepartment of Clinical Neurosciences/DIMSC, School of Medicine, Section of Psychiatry, Polytechnic University of Marche, 60121 Ancona, ItalyPolyedra, 64100 Teramo, ItalyNeomesia Mental Health, Villa Jolanda Hospital, 60035 Jesi, ItalyPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB Herts, UKPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, AL10 9AB Herts, UK<i>Background and Objectives</i>: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances. Despite several therapeutic approaches being available, both pharmacological and psychological, recently a growing interest has developed in using cannabis and synthetic cannabinoids stems from their consideration as more efficient and better tolerated alternatives for the treatment of this condition. The present paper aims to evaluate the clinical and therapeutic potentials of medical cannabis and synthetic cannabinoids in treating PTSD patients. <i>Methods</i>: A systematic electronic search was performed, including all papers published up to May 2019, using the following keywords (((cannabis[Title/Abstract]) OR (synthetic cannabinoids [Title/Abstract])) AND ((PTSD[Title/Abstract]) OR (Posttraumatic stress disorder[Title/Abstract]))) for the topics ‘Cannabis’, ‘Synthetic Cannabinoids’, ‘PTSD’, and MESH terms, on the PubMed, Cochrane Library, and Web of Science online databases. For data gathering purposes, PRISMA guidelines were followed. Results were organized into two groups, considering cannabis and synthetic cannabinoids as different therapeutic approaches for PTSD. <i>Results</i>: Present data show that cannabis and synthetic cannabinoids, both acting on the endocannabinoids system, may have a potential therapeutic use for improving PTSD symptoms, e.g., reducing anxiety, modulating memory-related processes, and improving sleep. <i>Conclusions</i>: Even though the current literature suggests that cannabis and synthetic cannabinoids may have a role in the treatment of PTSD, there is currently limited evidence regarding their safety and efficacy. Therefore, additional research is needed in order to better understand the effectiveness and therapeutic usage of these drug classes and monitor their safety.https://www.mdpi.com/1010-660X/55/9/525PTSDtraumaCBDcannabisendocannabinoid systemcannabinoidssynthetic cannabinoids |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Laura Orsolini Stefania Chiappini Umberto Volpe Domenico De Berardis Roberto Latini Gabriele Duccio Papanti John Martin Corkery |
spellingShingle |
Laura Orsolini Stefania Chiappini Umberto Volpe Domenico De Berardis Roberto Latini Gabriele Duccio Papanti John Martin Corkery Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review Medicina PTSD trauma CBD cannabis endocannabinoid system cannabinoids synthetic cannabinoids |
author_facet |
Laura Orsolini Stefania Chiappini Umberto Volpe Domenico De Berardis Roberto Latini Gabriele Duccio Papanti John Martin Corkery |
author_sort |
Laura Orsolini |
title |
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review |
title_short |
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review |
title_full |
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review |
title_fullStr |
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review |
title_full_unstemmed |
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review |
title_sort |
use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (ptsd): a systematic review |
publisher |
MDPI AG |
series |
Medicina |
issn |
1010-660X |
publishDate |
2019-08-01 |
description |
<i>Background and Objectives</i>: Post-traumatic stress disorder (PTSD) is a common psychiatric disorder resulting from a traumatic event, is manifested through hyperarousal, anxiety, depressive symptoms, and sleep disturbances. Despite several therapeutic approaches being available, both pharmacological and psychological, recently a growing interest has developed in using cannabis and synthetic cannabinoids stems from their consideration as more efficient and better tolerated alternatives for the treatment of this condition. The present paper aims to evaluate the clinical and therapeutic potentials of medical cannabis and synthetic cannabinoids in treating PTSD patients. <i>Methods</i>: A systematic electronic search was performed, including all papers published up to May 2019, using the following keywords (((cannabis[Title/Abstract]) OR (synthetic cannabinoids [Title/Abstract])) AND ((PTSD[Title/Abstract]) OR (Posttraumatic stress disorder[Title/Abstract]))) for the topics ‘Cannabis’, ‘Synthetic Cannabinoids’, ‘PTSD’, and MESH terms, on the PubMed, Cochrane Library, and Web of Science online databases. For data gathering purposes, PRISMA guidelines were followed. Results were organized into two groups, considering cannabis and synthetic cannabinoids as different therapeutic approaches for PTSD. <i>Results</i>: Present data show that cannabis and synthetic cannabinoids, both acting on the endocannabinoids system, may have a potential therapeutic use for improving PTSD symptoms, e.g., reducing anxiety, modulating memory-related processes, and improving sleep. <i>Conclusions</i>: Even though the current literature suggests that cannabis and synthetic cannabinoids may have a role in the treatment of PTSD, there is currently limited evidence regarding their safety and efficacy. Therefore, additional research is needed in order to better understand the effectiveness and therapeutic usage of these drug classes and monitor their safety. |
topic |
PTSD trauma CBD cannabis endocannabinoid system cannabinoids synthetic cannabinoids |
url |
https://www.mdpi.com/1010-660X/55/9/525 |
work_keys_str_mv |
AT lauraorsolini useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview AT stefaniachiappini useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview AT umbertovolpe useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview AT domenicodeberardis useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview AT robertolatini useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview AT gabrieleducciopapanti useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview AT johnmartincorkery useofmedicinalcannabisandsyntheticcannabinoidsinposttraumaticstressdisorderptsdasystematicreview |
_version_ |
1725885799696695296 |